Grifols Engineering S.A.

Grifols is a global healthcare company specializing in essential plasma-derived medicines and transfusion medicine, developing, producing, and providing innovative healthcare services and solutions in over 110 countries. Patient needs and the company's growing knowledge of chronic, rare, and life-threatening diseases drive its innovation in biopharmaceuticals to enhance quality of life. Grifols focuses on therapeutic areas such as neurology, immunology, hepatology, intensive care, pulmonology, hematology, and infectious diseases. As a pioneer, it operates the world's most diversified network of more than 400 plasma donation centers across North America, Europe, Africa, the Middle East, and China through a partnership with Shanghai RAAS. The company is committed to a sustainable business model, setting industry standards for continuous innovation, quality, safety, and ethical leadership, and has been recognized by TIME and Forbes as a top global company and employer.